Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.sciencedaily.com/releases/2022/09/220908120508.htm
0
0
Promising anti-cancer drug also may function as COVID-19 antiviral therapy: Study suggests small molecule inhibitor RK-33 can block multiple variants of the SARS-CoV-2 virus from replicating - Science Daily
+ 116 more
9/8/22 at 5:15pm
Organization
Science Daily
Authors
Details
74 words
Summarize
Cancer
Health
Drugs & Medications
Infectious Diseases
SARS-CoV-2
anti-cancer drug
RK-33
SARS-CoV
Findings from a new study suggest that an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...